CLINICAL_TRIALS
trial_result
· 2024-06-05
Clinical Trial Update: Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS [Phase 3]
Summary
A Phase 3 clinical trial evaluating somatropin in Japanese participants with Prader-Willi Syndrome has completed and posted results. The study assessed efficacy…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Prader-Willi Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2024-06-05